Clinical outcomes and safety of immune checkpoint inhibitors in patients with solid tumors and paraneoplastic syndromes Article

Open Access International Collaboration

cited authors

  • Nassar, Amin H.; El Zarif, Talal; Khalid, Ahmed Bilal; Rahme, Serena; Zhong, Caiwei; Kwak, Lucia; Salame, Marita; Farhat, Elias Bou; Freeman, Dory; El-Am, Edward; Ravishankar, Arjun; Ahmad, Bachar; Nana, Frank Aboubakar; Kaldas, David; Naqash, Abdul Rafeh; Sharon, Elad; LeBoeuf, Nicole R.; Cortellini, Alessio; Malgeri, Andrea; Gupta, Shruti; Al-Hader, Ahmad; Sparks, Jeffrey A.; Linnoila, Jenny; Hamnvik, Ole-Petter R.; Mouhieddine, Tarek H.; Marron, Thomas; Parikh, Kaushal; McKay, Rana R.; Dilling, Thomas; Choueiri, Toni K.; Adib, Elio; Najem, Elie; Kim, So Yeon; Sonpavde, Guru

authors

Publication Date

  • March 1, 2024

webpage

published in

category

keywords

  • Immune Checkpoint Inhibitors
  • Non-Small Cell Lung Cancer
  • PARANEOPLASTIC SYNDROME

volume

  • 12

issue

  • 3